BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15768350)

  • 1. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of hepatitis C in the United States.
    Kim WR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S30-4. PubMed ID: 12407574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C in state correctional facilities.
    Spaulding A; Greene C; Davidson K; Schneidermann M; Rich J
    Prev Med; 1999 Jan; 28(1):92-100. PubMed ID: 9973592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.
    Spaulding AC; Lally M; Rich JD; Dieterich DT
    AIDS Read; 1999 Oct; 9(7):481-91. PubMed ID: 12737140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
    Sulkowski MS; Thomas DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S263-9. PubMed ID: 15768333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A call to immunize the correctional population for hepatitis A and B.
    Gondles EF
    Am J Med; 2005 Oct; 118 Suppl 10A():84S-89S. PubMed ID: 16271547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and incarceration: dual epidemics.
    Wohl DA; Rosen D; Kaplan AH
    AIDS Read; 2006 May; 16(5):247-50, 257-60. PubMed ID: 16764066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexually transmitted infection and blood-borne virus screening in juvenile correctional facilities: a review of the literature and recommendations for Australian centres.
    Templeton DJ
    J Clin Forensic Med; 2006 Jan; 13(1):30-6. PubMed ID: 16084746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.
    Weinbaum CM; Sabin KM; Santibanez SS
    AIDS; 2005 Oct; 19 Suppl 3():S41-6. PubMed ID: 16251827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection among incarcerated women: epidemic behind bars.
    De Groot AS
    AIDS Read; 2000 May; 10(5):287-95. PubMed ID: 10851720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prevention in prisons and jails: obstacles and opportunities.
    Polonsky S; Kerr S; Harris B; Gaiter J; Fichtner RR; Kennedy MG
    Public Health Rep; 1994; 109(5):615-25. PubMed ID: 7938381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.